Drug Search Results
More Filters [+]

Amlexanox

Alternative Names: amlexanox, aphthasol
Latest Update: 2024-01-17
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Immunomodulator,FGFR Inhibitor,HSP90 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Bangladesh | Canada | Egypt | Germany | India | Ireland | Portugal | Sweden

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Amlexanox

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events